144 related articles for article (PubMed ID: 28865358)
1. Fabrication of all-trans-retinoic acid-loaded biocompatible precirol: A strategy for escaping dose-dependent side effects of doxorubicin.
Sabzichi M; Mohammadian J; Ghorbani M; Saghaei S; Chavoshi H; Ramezani F; Hamishehkar H
Colloids Surf B Biointerfaces; 2017 Nov; 159():620-628. PubMed ID: 28865358
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D-Loaded Nanostructured Lipid Carrier (NLC): A New Strategy for Enhancing Efficacy of Doxorubicin in Breast Cancer Treatment.
Sabzichi M; Mohammadian J; Mohammadi M; Jahanfar F; Movassagh Pour AA; Hamishehkar H; Ostad-Rahimi A
Nutr Cancer; 2017; 69(6):840-848. PubMed ID: 28742387
[TBL] [Abstract][Full Text] [Related]
3. Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line.
Tupal A; Sabzichi M; Bazzaz R; Fathi Maroufi N; Mohammadi M; Pirouzpanah SM; Ramezani F
Nutr Cancer; 2020; 72(4):653-661. PubMed ID: 31390910
[TBL] [Abstract][Full Text] [Related]
4. Sustained release of melatonin: A novel approach in elevating efficacy of tamoxifen in breast cancer treatment.
Sabzichi M; Samadi N; Mohammadian J; Hamishehkar H; Akbarzadeh M; Molavi O
Colloids Surf B Biointerfaces; 2016 Sep; 145():64-71. PubMed ID: 27137804
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
[TBL] [Abstract][Full Text] [Related]
6. Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells.
Mohammadian J; Mahmoudi S; Pourmohammad P; Pirouzpanah M; Salehnia F; Maroufi NF; Samadi N; Sabzichi M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2315-2323. PubMed ID: 32653978
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles.
Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J
Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism.
Maroufi NF; Vahedian V; Mazrakhondi SAM; Kooti W; Khiavy HA; Bazzaz R; Ramezani F; Pirouzpanah SM; Ghorbani M; Akbarzadeh M; Hajipour H; Ghanbarzadeh S; Sabzichi M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jan; 393(1):1-11. PubMed ID: 31372697
[TBL] [Abstract][Full Text] [Related]
9. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
10. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.
Czeczuga-Semeniuk E; Wołczyński S; Dabrowska M; Dziecioł J; Anchim T
Folia Histochem Cytobiol; 2004; 42(4):221-7. PubMed ID: 15704648
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-enhanced delivery of doxorubicin/all-trans retinoic acid-loaded nanodiamonds into tumors.
Li H; Zeng D; Wang Z; Fang L; Li F; Wang Z
Nanomedicine (Lond); 2018 May; 13(9):981-996. PubMed ID: 29536804
[TBL] [Abstract][Full Text] [Related]
12. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
[TBL] [Abstract][Full Text] [Related]
13. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells.
Minaei A; Sabzichi M; Ramezani F; Hamishehkar H; Samadi N
Mol Biol Rep; 2016 Feb; 43(2):99-105. PubMed ID: 26748999
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
Alinejad V; Hossein Somi M; Baradaran B; Akbarzadeh P; Atyabi F; Kazerooni H; Samadi Kafil H; Aghebati Maleki L; Siah Mansouri H; Yousefi M
Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
18. Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.
Hu L; Lv JF; Zhuo W; Zhang CM; Zhou HH; Fan L
J Pharm Pharmacol; 2016 Sep; 68(9):1193-202. PubMed ID: 27366899
[TBL] [Abstract][Full Text] [Related]
19. Folate-Targeted Nanostructured Lipid Carriers (NLCs) Enhance (Letrozol) Efficacy in MCF-7 Breast Cancer Cells.
Sabzichi M; Mohammadian J; Yari Khosroushahi A; Bazzaz R; Hamishehkar H
Asian Pac J Cancer Prev; 2016 Dec; 17(12):5185-5188. PubMed ID: 28124885
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis.
Xia L; Wurmbach E; Waxman S; Jing Y
Leukemia; 2006 Jun; 20(6):1009-16. PubMed ID: 16572199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
